An observational study in Infections, Helicobacter, sponsored by Carol Davila University of Medicine and Pharmacy. Completed at 1 site in Romania. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-21.
Sponsored by Carol Davila University of Medicine and Pharmacy · Observational
Observational study, voluntary participation, 12 months, studying Helicobacter pylori prevalence.
Observational study, voluntary participation, 12 months, studying Helicobacter pylori prevalence.
The aim of the study is to evaluate the prevalence of H. pylori infection in several areas of the Southern Regions of Romania, considered as vulnerable pertaining to the access of health services.
Fecal Helicobacter pylori will be tested, together with antibiotic susceptibility.
186 studies on the registry are indexed under Helicobacter Infections; 32 are open to participants now.
This study's enrollment of 708 is above the median of 180 across 47 observational studies indexed under Helicobacter Infections.
Browse Helicobacter Infections studies →Carol Davila University of Medicine and Pharmacy is the lead sponsor of 25 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult population from Southern Regions of Romania, from rural vulnerable areas concerning access to health services.
Exclusion Criteria:
Helicobacter pylori infection rate
rate of fecal antigen test divided by total number of tests (fecal Helicobacter test)
Time frame: 12 months
Antibiotic susceptibility rate
rate of antibiotic (x) susceptibility divided by total number of tests (antibiotic susceptibility test)
Time frame: 12 months
This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Carol Davila University of Medicine and Pharmacy